Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
1. To compare the safety and efficacy of ABT-494 versus abatacept intravenous (IV) for the treatment of signs and symptoms of rheumatoid arthritis (RA) in bDMARD-inadequate response (bDMARD-IR) or bDMARD-intolerant subjects with moderately to severely active RA. 2. To evaluate the long-term safety, tolerability, and efficacy of ABT-494 in subjects with RA.
Critère d'inclusion
- Moderately to Severely Active Rheumatoid Arthritis (RA)